Profusa Lumee PAD study meets primary endpoints in U.S. trial
Profusa (Nasdaq: PFSA) presented FDA-advised pilot phase results at Paris Vascular Insights on…
Vascular surgeon with 18 years of experience, shares one simple exercise for people with Peripheral Artery Disease
Peripheral artery disease, or PAD, affects millions worldwide and often leads to excruciating pain, difficulties in walking, and…